Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


DexCom Q2 Adj. EPS $0.76 Beats $0.45 Estimate, Sales $595.10M Beat $551.27M Estimate


Benzinga | Jul 29, 2021 04:24PM EDT

DexCom Q2 Adj. EPS $0.76 Beats $0.45 Estimate, Sales $595.10M Beat $551.27M Estimate

DexCom (NASDAQ:DXCM) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.45 by 68.89 percent. This is a 3.8 percent decrease over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $595.10 million which beat the analyst consensus estimate of $551.27 million by 7.95 percent. This is a 31.72 percent increase over sales of $451.80 million the same period last year.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC